NCCM
CORV

Nine Chapters Capital Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Nine Chapters Capital Management’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-11,500
Closed -$90K – 1244
2014
Q2 		$90K Buy
+11,500
New +$86.9K 0.01% 883

Other funds holding CORV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIG
Fortress Investment Group New York $531M AUM 12.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Nine Chapters Capital Management's CORV Position: Q3 2014 in Review

Nine Chapters Capital Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q3 2014, closing a stake of 11,500 shares — an estimated $90K sold.

Nine Chapters Capital Management first reported a position in CORV in Q2 2014 and held it in 1 quarter. The position peaked at $90K in Q2 2014. 27 funds tracked by Wall St. Rank hold CORV as of Q3 2014.

  • Nine Chapters Capital Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q3 2014 after selling out during the quarter.
  • Nine Chapters Capital Management sold 11,500 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q3 2014, an estimated $90K.
  • Nine Chapters Capital Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2014 and held it in 1 quarter.
  • Nine Chapters Capital Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $90K in Q2 2014.
  • 27 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q3 2014.

Based on Nine Chapters Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.